Janux Therapeutics
Price & Volume
Stats
See moreOpen | $13.95 |
Previous Close | $13.91 |
Day Range | $13.91-$14.23 |
52W Range | $13.26-$47.58 |
Market Cap | $840.8M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $10M |
Revenue Growth (YoY) | 2,177.9% |
Gross Profit (12 Mos) | -$105.1M |
Diluted EPS | -$1.67 |
News
See moreYahoo Finance • 17 days ago
Janux Completes Phase 1a Dose-escalation In Phase 1 JANX008 Study; Expansion Cohorts To Commence
Yahoo Finance • 17 days ago
Here are the most and least likely M&A targets in biotech, according to Truist
Yahoo Finance • last month
Do JANX007’s Interim Results Put Janux Therapeutics’ (JANX) TRACTr Platform Competitiveness to the Test?
Yahoo Finance • last month
Stocks making the biggest moves midday: Maplebear, Boeing, Credo Technology, XPO, MongoDB & more
About
CEO | Dr. David Alan Campbell Ph.D. |
Address | 10955 Vista Sorrento Parkway, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 109 |
